Dear Sachin Yadav Ji,
We're sorry to hear about your diagnosis. An aggressive metastatic hepatic tumor, such as mass-forming cholangiocarcinoma or hepatocellular carcinoma (HCC), requires a comprehensive treatment approach tailored to your specific condition.
Treatment Options:
Surgical Intervention:
- Resection: If the tumour is localized and you have sufficient liver function, surgical removal of the tumour may be considered. However, in cases of metastasis, surgery might not be feasible.
- Liver Transplant: For certain patients with early-stage HCC, liver transplantation could be an option.
Systemic Therapies:
- Chemotherapy: Systemic chemotherapy is commonly used for unresectable or metastatic cholangiocarcinoma.
- Targeted Therapy: Drugs targeting specific genetic mutations or pathways in cancer cells are available for HCC and cholangiocarcinoma.
- Immunotherapy: Agents that enhance the immune system's ability to fight cancer, such as checkpoint inhibitors, have shown promise in treating advanced liver cancers.
Locoregional Therapies:
- Transarterial Chemoembolization (TACE): This procedure delivers chemotherapy directly to the liver tumour while blocking its blood supply.
- Radioembolization (Selective Internal Radiation Therapy—SIRT) involves injecting tiny radioactive beads into the liver's blood vessels to target the tumour.
Palliative Care:
- Focuses on relieving symptoms and improving quality of life, especially when curative treatments are not an option.
Next Steps and How HexaHealth can help:
- Discussing these options with a multidisciplinary team, including hepatologists, oncologists, and surgeons, is crucial to determine the most appropriate treatment plan for your situation.
- For more information, please feel free to connect with our care specialists at HexaHealth. We will provide you with opinions from multiple specialists, taking a multidisciplinary approach to financing and care assistance.